China approves 3rd Sinopharm Covid vaccine for clinical trial

The green light to begin testing comes after two inactivated vaccines from Sinopharm were approved and widely used both at home and in developing countries.

China has approved the third Covid-19 vaccine from Sinopharm Group Co. to start clinical trials, the company said.

A nurse prepares the first dose from a vial of Moderna COVID-19 vaccine to be administered in Britain at the West Wales General Hospital in Carmarthen, Wales, Wednesday April 7, 2021. The Moderna vaccine is the third vaccine to be approved for use in the UK, which is to be given to patients in Wales from Wednesday, and the UK has so far ordered 17 million doses of the Moderna jab. (Jacob King/Pool via AP) (AP)

The green light to begin testing comes after two inactivated vaccines from Sinopharm were approved and widely used both at home and in developing countries.

The latest one is a recombinant vaccine that includes parts of the coronavirus’s spike protein to stimulate immune response, according to a release posted on the company’s official WeChat account on Saturday.